Come up with a name for your new list and we'll add to it:
Earthgenes Pharmaceuticals raised a round of funding on August 12, 2009. Investors include
National Science Foundation.
Earthgenes Pharmaceuticals is a company that received a STTR Phase II grant for a project entitled: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli…